BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 17464296)

  • 1. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases.
    Casero RA; Marton LJ
    Nat Rev Drug Discov; 2007 May; 6(5):373-90. PubMed ID: 17464296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of targeting polyamine metabolism as an antineoplastic strategy: unique targets for polyamine analogues.
    Casero RA; Frydman B; Stewart TM; Woster PM
    Proc West Pharmacol Soc; 2005; 48():24-30. PubMed ID: 16416654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyamine transport in parasites: a potential target for new antiparasitic drug development.
    Reguera RM; Tekwani BL; Balaña-Fouce R
    Comp Biochem Physiol C Toxicol Pharmacol; 2005 Feb; 140(2):151-64. PubMed ID: 15907761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyamine catabolism: target for antiproliferative therapies in animals and stress tolerance strategies in plants.
    Tavladoraki P; Cona A; Federico R; Tempera G; Viceconte N; Saccoccio S; Battaglia V; Toninello A; Agostinelli E
    Amino Acids; 2012 Feb; 42(2-3):411-26. PubMed ID: 21874532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.
    Barret JM; Kruczynski A; Vispé S; Annereau JP; Brel V; Guminski Y; Delcros JG; Lansiaux A; Guilbaud N; Imbert T; Bailly C
    Cancer Res; 2008 Dec; 68(23):9845-53. PubMed ID: 19047165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs affecting the cell cycle via actions on the polyamine metabolic pathway.
    Ackermann JM; Pegg AE; McCloskey DE
    Prog Cell Cycle Res; 2003; 5():461-8. PubMed ID: 14593741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors.
    Seiler N
    Curr Drug Targets; 2003 Oct; 4(7):537-64. PubMed ID: 14535654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting polyamine metabolism for cancer therapy and prevention.
    Murray-Stewart TR; Woster PM; Casero RA
    Biochem J; 2016 Oct; 473(19):2937-53. PubMed ID: 27679855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mepacrine antagonises tumour cell growth induced by natural polyamines.
    Rossi T; Coppi A; Bruni E; Ruberto A; Giudice S; Baggio G
    Anticancer Res; 2008; 28(5A):2765-8. PubMed ID: 19035307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyamines and cancer: old molecules, new understanding.
    Gerner EW; Meyskens FL
    Nat Rev Cancer; 2004 Oct; 4(10):781-92. PubMed ID: 15510159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyamines: metabolism and implications in human diseases.
    Moinard C; Cynober L; de Bandt JP
    Clin Nutr; 2005 Apr; 24(2):184-97. PubMed ID: 15784477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyamine analogues as anticancer drugs.
    Wallace HM; Fraser AV
    Biochem Soc Trans; 2003 Apr; 31(2):393-6. PubMed ID: 12653646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spermidine/spermine-N(1)-acetyltransferase: a key metabolic regulator.
    Pegg AE
    Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E995-1010. PubMed ID: 18349109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging concepts in targeting the polyamine metabolic pathway in epithelial cancer chemoprevention and chemotherapy.
    Basuroy UK; Gerner EW
    J Biochem; 2006 Jan; 139(1):27-33. PubMed ID: 16428316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyamines metabolism and breast cancer: state of the art and perspectives.
    Cervelli M; Pietropaoli S; Signore F; Amendola R; Mariottini P
    Breast Cancer Res Treat; 2014 Nov; 148(2):233-48. PubMed ID: 25292420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both?
    Wang Y; Casero RA
    J Biochem; 2006 Jan; 139(1):17-25. PubMed ID: 16428315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyamine catabolism in carcinogenesis: potential targets for chemotherapy and chemoprevention.
    Battaglia V; DeStefano Shields C; Murray-Stewart T; Casero RA
    Amino Acids; 2014 Mar; 46(3):511-9. PubMed ID: 23771789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular basis for the use of polyamine analogs--inhibitors of polyamine synthesis enzymes].
    Berezov TT; Fedoronchuk TV
    Vopr Med Khim; 1997; 43(5):280-9. PubMed ID: 9446318
    [No Abstract]   [Full Text] [Related]  

  • 19. Polyamine analogues - an update.
    Wallace HM; Niiranen K
    Amino Acids; 2007 Aug; 33(2):261-5. PubMed ID: 17443267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyamine metabolism in the Microsporidia.
    Bacchi CJ; Yarlett N; Weiss LM
    Biochem Soc Trans; 2003 Apr; 31(2):420-3. PubMed ID: 12653651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.